YK-2-69
YK-2-69 is a highly selective DYRK2 inhibitor with an IC50 value of 9 nM. YK-2-69 specifically interacts with Lys-231 and Lys-234 of DYRK2 and can be utilized in researches related to prostate cancer[1].
Product Specifications
CAS Number
[2619846-89-6]
UNSPSC
12352005
Target
DYRK
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yk-2-69.html
Purity
99.57
Solubility
DMSO : 5.83 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1CCN(CC1)CC)C2=CN=C(NC3=NC(C4=CC5=C(N=C(N(C)C)S5)C=C4)=C(F)C=N3)C=C2
Molecular Formula
C25H27FN8OS
Molecular Weight
506.60
References & Citations
[1]Yuan K, et al. Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer. Nat Commun. 2022 May 25;13 (1) :2903.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DYRK2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6131507-01 0.1 mL
GNAI1 (Guanine Nucleotide-binding Protein G(i) Subunit alpha-1, Adenylate Cyclase-inhibiting G alpha Protein) (AP)
Ask
View Details 
MBS6131507-02 5x 0.1 mL
GNAI1 (Guanine Nucleotide-binding Protein G(i) Subunit alpha-1, Adenylate Cyclase-inhibiting G alpha Protein) (AP)
Ask
View Details 
MBS7094999 Inquire
Recombinant Clostridium perfringens UPF0182 protein CPE0011 (CPE0011), partial
Ask
View Details 
